Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke: A Pilot Study

Jiandao Yang; Huazheng Liang; Yanyan Song; Lingda Shen; Shaoshi Wang

doi:10.1007/s12264-016-0020-2

Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke: A Pilot Study

Jiandao Yang, Huazheng Liang, Yanyan Song, Lingda Shen, Shaoshi Wang

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	202-203
Number of pages	2
Journal	Neuroscience Bulletin
Volume	32
Issue number	2
DOIs	https://doi.org/10.1007/s12264-016-0020-2
Publication status	Published - 1 Apr 2016
Externally published	Yes

Access to Document

10.1007/s12264-016-0020-2

Cite this

@article{b7359532e19845e8962e2cb6e9be3163,

title = "Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke: A Pilot Study",

author = "Jiandao Yang and Huazheng Liang and Yanyan Song and Lingda Shen and Shaoshi Wang",

year = "2016",

month = apr,

day = "1",

doi = "10.1007/s12264-016-0020-2",

language = "English",

volume = "32",

pages = "202--203",

journal = "Neuroscience Bulletin",

issn = "1673-7067",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke

T2 - A Pilot Study

AU - Yang, Jiandao

AU - Liang, Huazheng

AU - Song, Yanyan

AU - Shen, Lingda

AU - Wang, Shaoshi

PY - 2016/4/1

Y1 - 2016/4/1

UR - http://www.scopus.com/inward/record.url?scp=84960124114&partnerID=8YFLogxK

U2 - 10.1007/s12264-016-0020-2

DO - 10.1007/s12264-016-0020-2

M3 - Letter

C2 - 26960426

AN - SCOPUS:84960124114

SN - 1673-7067

VL - 32

SP - 202

EP - 203

JO - Neuroscience Bulletin

JF - Neuroscience Bulletin

IS - 2

ER -

Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke: A Pilot Study

Access to Document

Other files and links

Cite this